A detailed history of Novo Holdings transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Novo Holdings holds 490,000 shares of BMRN stock, worth $32.6 Million. This represents 2.41% of its overall portfolio holdings.

Number of Shares
490,000
Previous 490,000 -0.0%
Holding current value
$32.6 Million
Previous $40.3 Million 14.62%
% of portfolio
2.41%
Previous 2.88%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $2.98 Million - $3.69 Million
40,000 Added 8.89%
490,000 $40.3 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $3.81 Million - $4.93 Million
50,000 Added 12.5%
450,000 $43.4 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $2.83 Million - $3.27 Million
32,620 Added 8.88%
400,000 $34.7 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $4.36 Million - $5.83 Million
49,680 Added 15.64%
367,380 $35.7 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $16,186 - $21,726
200 Added 0.06%
317,700 $32.9 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $22.7 Million - $27.6 Million
317,500 New
317,500 $26.3 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.